MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2016 International Congress

    Relationship between the MDS-UPDRS and quality of life in Parkinson’s disease: A large international multicenter study of 3206 patients (the QUALPD study)

    M. Škorvánek, P. Martinez-Martin, N. Kovacs, I. Zezula, M. Rodriguez-Violante, J.C. Corvol, P. Taba, K. Seppi, O. Levin, A.E. Schrag, T. Foltynie, M. Alvarez-Sanchez, T. Arakaki, Z. Aschermann, I. Aviles-Olmos, E. Benchetrit, C. Benoit, A. Bergareche-Yarza, A. Cervantes-Arriaga, A. Chade, F. Cormier, V. Datieva, D.A. Gallagher, N. Garretto, Z. Gdovinova, O. Gerschanik, M. Grofik, V. Han, J. Huang, L. Kadastik-Eerme, M.M. Kurtis, G. Mangone, J.C. Martinez-Castrillo, A. Mendoza-Rodriguez, M. Minar, H.P. Moore, M. Muldmaa, C. Mueller, B. Pinter, W. Poewe, K. Rallmann, E. Reiter, C. Rodriguez-Blazquez, C. Singer, B.C. Tilley, P. Valkovic, C.G. Goetz, G.T. Stebbins (Kosice, Slovakia (Slovak Republic))

    Objective: To evaluate the relationship between the International Parkinson and Movement Disorder Society – Unified Parkinson's disease Rating Scale (MDS-UPDRS) and Quality of Life (QoL)…
  • 2016 International Congress

    The role of depression in suicidal ideation in a sample of patients with Parkinson’s disease

    M.M. Dumitru (Iasi, Romania)

    Objective: The objective of this study was to assess the frequency of suicidal ideation and suicide attempts in a sample of consecutive patients with Parkinson's…
  • 2016 International Congress

    Preclinical evaluation of sub-anesthetic ketamine infusion to reduce L-DOPA-induced dyskinesias: Is it a ‘chemical’ DBS?

    T. Falk, M.J. Bartlett, T. Ye, L.B. Lazarus, M.L. Heien, S.L. Cowen, S.J. Sherman (Tucson, AZ, USA)

    Objective: To evaluate mechanism of long-term activity of sub-anesthetic ketamine infusion to reduce L-DOPA-induced dyskinesias (LID). Background: Ketamine is an anesthetic that, when administered as…
  • 2016 International Congress

    Greater incidence of depressive symptoms in atypical parkinsonism: Importance of early screening

    L. Almeida, B. Ahmed, R. Walz, S. De Jesus, A. Patterson, D. Martinez-Ramirez, D. Vaillancourt, D. Bowers, H. Ward, M.S. Okun, M. Armstrong, N. McFarland (Gainesville, FL, USA)

    Objective: To evaluate the incidence of depressive symptoms in Parkinsonian patients in a large cohort followed at a tertiary movement disorders center. Background: Despite relative…
  • 2016 International Congress

    Life satisfaction in Parkinson’s disease – associated factors

    K. Rosqvist, P. Hagell, P. Odin, S. Iwarsson, H. Ekström, M.H. Nilsson (Lund, Sweden)

    Objective: To identify factors associated with life satisfaction (LS) in people with Parkinson's disease (PD), including a specific focus on those with late stage PD.…
  • 2016 International Congress

    Relation between personality trait and depression in Parkinson’s disease

    A. Kumon, Y. Kobayashi, M. Saruwatari, N. Kawashima, K. Hasegawa (Sagamihara, Japan)

    Objective: 1. To investigate personality trait of patients with Parkinson's disease (PD). 2. To clarify the relationship between personality trait and depression in patients with…
  • 2016 International Congress

    Patient case reports supporting a long-term effect of sub-anesthetic ketamine infusion in reducing L-DOPA-induced dyskinesias

    S.J. Sherman, T. Falk (Tucson, AZ, USA)

    Objective: To evaluate possible long-term anti-dyskinetic activity of low-dose sub-anesthetic ketamine infusion from a retrospective chart review. Background: Repurposing drugs that have already been proven…
  • 2016 International Congress

    Long-term efficacy of safinamide on mood in Parkinsonian patients with fluctuations

    C. Cattaneo, E. Mueller, M. Sardina (Bresso, Italy)

    Objective: The present post-hoc analysis of the results of two pivotal trials (016 and 018) investigated the effects of safinamide 100 mg/day on mood in…
  • 2016 International Congress

    Impact of self-efficacy education on physical and psychosocial functioning in newly-diagnosed Parkinson patients

    D. Cook, C. McRae, R. Kumar (Englewood, CO, USA)

    Objective: To evaluate whether this program improves physical and psychosocial functioning in newly-diagnosed persons with Parkinson's disease (PWP) over the 12-month period of the intervention…
  • 2016 International Congress

    Profile of depressive symptoms in Parkinson’s disease patients and a population-based elderly cohort

    K. Hückelheim, E.J. Vollstedt, S. Tunc, J. Hampf, J. Graf, V. Tadic, C. Klein, M. Kasten (Lübeck, Germany)

    Objective: To examine the prevalences and profiles of depressive symptoms in Parkinson's disease (PD) patients and population-based control groups by using the Beck depression inventory.…
  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley